Subscribe to RSS
DOI: 10.1055/s-0029-1216986
An Efficient Hemisynthesis of 20- and 21-[¹³C]-Labeled Cortexolone: A Model for the Study of Skin Sensitization to Corticosteroids
Publication History
Publication Date:
03 September 2009 (online)
Abstract
A method is described for the synthesis of isotopomers of cortexolone from the commercially available andros-4-ene-3,17-dione. The strategy is based on the use of K¹³CN for labeling at position 20 and of ¹³CH3MgI, generated in situ, for labeling at position 21. Because of the early introduction of the [¹³C] labeling, our efforts aimed at reproducible experimental procedures giving high yields with respect to the isotope containing precursors. During the development of this hemisynthesis, we noted that judicious choice of protective groups was essential as this could lead not only to mixtures or unstable intermediates but also influence considerably the output of reactions.
Key words
steroids - medicinal chemistry - isotope labeled - allergen synthesis - protecting groups
- Supporting Information for this article is available online:
- Supporting Information
- 1
Schimmer BP.Parker KL. In Goodman & Gilman’s : The Pharmacological Basis of Therapeutics, 11th ed.Brunton LL.Lazo JS.Parker KL. McGraw Hill; New York: 2006. p.1587-1612 -
2a
Wilkinson SM.Cartwright PH.English JSC. Lancet 1991, 337: 761 -
2b
Lauerma AI. Contact Dermatitis 1991, 24: 123 -
2c
Dooms-Goossens A.Morren M. Contact Dermatitis 1992, 26: 182 -
2d
Matura M.Goossens A. Allergy 2000, 55: 698 -
2e
Hennge UR.Ruzicka T.Schwartz RA.Cork MJ. J. Am. Acad. Dermatol. 2006, 54: 1 -
3a
Lepoittevin J.-P.Drieghes J.Goossens A. Arch Dermatol. 1995, 131: 31 -
3b
Bircher AJ.Thürlimann W.Hunziker Th.Pasche-Koo F.Hunziker N.Perrenoud D.Elsner P.Schultheiss R. Dermatology 1995, 191: 109 ; the author list also includes members of the Swiss contact dermatitis research group -
3c
Isaksson M.Andersen KE.Brandão FM.Bruynzeel DP.Bruze M.Camarasa JG.Diepgen T.Ducombs G.Frosch PJ.Goossens A.Lahti A.Menné T.Rycroft RJG.Seidenari S.Shaw S.Tosti A.Wahlberg JE.White IR.Wilkinson JD. Contact Dermatitis 2000, 42: 27 - 4
Rustemeyer T.van Hoogstraten IMW.von Blomberg BME.Scheper RJ. In Textbook of Contact DermatitisRycroft RJG.Menné T.Frosch PJ.Lepoittevin J.-P. Springer-Verlag; Berlin: 2001. p.13-58 - 5
Lepoittevin J.-P. In Textbook of Contact DermatitisRycroft RJG.Menné T.Frosch PJ.Lepoittevin J.-P. Springer-Verlag; Berlin: 2001. p.59-89 -
6a
Bundgaard H. Arch. Pharm. Chem., Sci. Ed. 1980, 8: 83 -
6b
Matura M.Lepoittevin J.-P.Arbez-Gindre C.Goossens A. Contact Dermatitis 1998, 38: 106 -
7a
Demoulin JD.Armbruster A.-M.Pullman B. J. Quantum Chem. 1979, 16: 631 -
7b
Lo TWC.Westwood ME.McLellan AC.Selwood T.Thornalley PJ. J. Biol. Chem. 1994, 269: 32299 -
7c
Wilkinson SM.Jones MF. Br. J. Dermatol. 1996, 165: 225 -
8a
Franot C.Benezra C.Lepoittevin J.-P. Bioorg. Med. Chem. 1993, 1: 389 -
8b
Goetz G.Meschkat E.Lepoittevin J.-P. Bioorg. Med. Chem. Lett. 1999, 9: 1141 - 9
Patchett AA. In Biographical Memoirs, National Academy of Sciences Vol. 81: The National Academy Press; Washington: 2002. p.278-293 -
10a
Andrews DR.Giusto RA.Sudhakar AR. Tetrahedron Lett. 1996, 37: 3417 -
10b
Batist JNM,Marx AF,van Zoest WJ, andKapur JC. inventors; European Patent, EP 0263569. ; Chem. Abstr. 1988, 109, 129460 -
10c
Barton DHR.Motherwell WB.Zard SZ. J. Chem. Soc., Chem. Commun. 1981, 774 -
10d
Daniewski AR.Wojciechowska W. Synthesis 1984, 132 -
10e
Murahashi S.-I.Saito TS.Hanaoka H.Murakami Y.Naota T.Kumobayashi H.Akutagawa S. J. Org. Chem. 1993, 58: 2929 -
10f
Lett R, andMelnyk O. inventors; US Patent, US 5723638. ; Chem. Abstr. 1996, 124, 176619 -
11a
Horiguchi Y.Nakamura E.Kuwajima I. Org. Synth. 1995, 73: 123 -
11b
Batist JNM.Barendse NCME.Marx AF. Steroids 1990, 55: 109 -
11c
VanRheenen VH. inventors; US Patent, US 4500461. ; Chem. Abstr. 1985, 103, 22844 -
11d
Livingston DA.Petre JE.Bergh CL. J. Am. Chem. Soc. 1990, 112: 6449 -
11e
Reid JG.Debiak-Krook T. Tetrahedron Lett. 1990, 31: 3669 -
11f
VanRheenen VH. inventors; European Patent, EP 0153001. ; Chem. Abstr. 1986, 105, 60816 -
11g
Carruthers NI.Andrews DR.Garshasb S.Giusto RA. J. Chem. Soc., Perkin Trans. 1 1992, 1195 -
11h
Nitta I.Fujimori S.Ueno H. Bull. Chem. Soc. Jpn. 1985, 58: 978 -
11i
Carruthers NI.Garshasb S. J. Org. Chem. 1992, 57: 961 -
12a
Dauben HJ.Löken B.Ringold HJ. J. Am. Chem. Soc. 1954, 76: 1359 -
12b
Nitz TJ.Paquette LA. Tetrahedron Lett. 1984, 25: 3047 -
13a
Jackson WR.Jacobs HA.Jayatilake GS.Matthews BR.Watson KG. Aust. J. Chem. 1990, 43: 2045 -
13b
Luly JR.Hsiao CN.BaMaung N.Plattner JJ. J. Org. Chem. 1988, 53: 6109 - 14
Arbez-Gindre C.Berl V.Lepoittevin J.-P. Chem. Commun. 1999, 431 - 15
Moriarty RM.John LS.Du PC. J. Chem. Soc., Chem. Commun. 1981, 641 - 16
Moriarty RM. J. Org. Chem. 2005, 70: 2893 -
17a
Ringold HJ.Stork G. J. Am. Chem. Soc. 1958, 80: 250 -
17b
Ringold HJ.Perez Ruelas J.Batres E.Djerassi C. J. Am. Chem. Soc. 1959, 81: 3712 -
17c
Rothman ES.Perlstein T.Wall ME. J. Org. Chem. 1960, 25: 1966 -
17d
Nitta I.Fujimori S.Ueno H. Bull. Chem. Soc. Jpn. 1985, 58: 978 - 18
Moreland WT. J. Org. Chem. 1956, 21: 820 - 20
Bodor N.Fey L.Kircz M.Hodosan F. Rev. Roum. Chim. 1964, 9: 147 ; Chem. Abstr. 1964, 61, 61819 -
21a
Gadsby B, andLeeming MRG. inventors; US Patent, US 3646012. ; Chem. Abstr. 1969, 71, 81648 -
21b
Bradford HW. inventors; US Patent, US 3444160. ; Chem. Abstr. 1969, 71, 61687 - 22
Numazawa M.Nagaoka M. J. Org. Chem. 1985, 50: 81 - 23
Julian PL.Meyer EW.Ryden I. J. Am. Chem. Soc. 1950, 72: 367 - 24
Ringold HJ.Rosenkranz G.Sondheimer F. J. Am. Chem. Soc. 1956, 78: 820
References
THF containing a certain amount of peroxide (titration with KI and thiosulfate) was prepared as follows: In a typical procedure, THF was exposed to sunlight in an open bottle until the peroxide content reached the expected value. Alternatively, THF could be first distilled from CaO before exposure to sunlight. Fresh and aged THF may be combined to give the proper peroxide content.